Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / E•••••••• G•••• I•••

PCP Announces Sale of E•••••••• G•••• I••• to E•••••••

Exit to a strategic buyerannouncedannounced Oct 31, 2018Fact
What happened
Target
E•••••••• G•••• I•••
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • E•••••••Strategic acquirerconfirmed
    “PCP Announces Sale of E•••••••• G•••• I••• to E•••••••”
  • S••••• M• E••••Deal partnerconfirmed
    “This excellence has allowed the Company to experience significant growth and expand its service offerings over the last number of years,” said S••••• M• E••••, Managing Partner at PCP.”
Sell side
  • P••••••••• C•••••• P•••••••Sellerconfirmed
    “October 31, 2018 - P••••••••• C•••••• P••••••• (“ PCP ”), a leading Canadian healthcare-focused private equity fund, is pleased to announce the sale of E•••••••• G•••• I••• (“ E•••••••• ”) to E••••••• Scientific (EUFI.PA), a global scientific leader in bioanalytical testing (“ E••••••• ”).”
Side not stated
Evidence
“PCP Announces Sale of E•••••••• G•••• I••• to E•••••••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 16, 2026
PCP Announces Sale of E•••••••• G•••• I••• to E••••••• | Private Equity Intelligence | DFX